Compare RDY & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | WMS |
|---|---|---|
| Founded | 1984 | 1966 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.6B |
| IPO Year | 2001 | 2014 |
| Metric | RDY | WMS |
|---|---|---|
| Price | $12.22 | $126.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $16.90 | ★ $180.63 |
| AVG Volume (30 Days) | ★ 2.2M | 603.8K |
| Earning Date | 05-12-2026 | 05-21-2026 |
| Dividend Yield | ★ 0.52% | 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $3,050,376,000.00 |
| Revenue This Year | $7.72 | $5.23 |
| Revenue Next Year | $3.50 | $12.79 |
| P/E Ratio | ★ $18.67 | $57.38 |
| Revenue Growth | N/A | ★ 5.03 |
| 52 Week Low | $11.36 | $124.75 |
| 52 Week High | $15.67 | $179.32 |
| Indicator | RDY | WMS |
|---|---|---|
| Relative Strength Index (RSI) | 53.86 | 34.74 |
| Support Level | $12.09 | N/A |
| Resistance Level | $12.48 | $155.03 |
| Average True Range (ATR) | 0.18 | 3.52 |
| MACD | 0.03 | -0.58 |
| Stochastic Oscillator | 82.25 | 9.62 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.